Baseline sarcopenia and subsequent dementia after incident atrial fibrillation or flutter in the UK Biobank

BACKGROUND: The association between sarcopenia and dementia after incident atrial fibrillation or flutter (AF/flutter) remains uncertain. METHODS: We studied 30,743 UK Biobank participants free of AF/flutter at recruitment who subsequently had a first recorded AF/flutter event. Sarcopenia was assessed at recruitment; dementia follow-up began at that event. Analyses used Cox and Fine-Gray models, propensity-score matching and restricted cubic splines. Exploratory analyses tested interactions with AF/flutter, heart failure and coronary artery disease status at entry. RESULTS: Sarcopenia was present in 2,279 participants (7.4%). Over a median 4.27 years after AF/flutter entry, 1,155 developed dementia. Recruitment preceded entry by a median 8.50 years. Fully adjusted analyses included 26,430 participants and 998 all-cause dementia events. Sarcopenia was associated with all-cause dementia in Cox (hazard ratio [HR], 1.41; 95% confidence interval [CI], 1.16-1.72) and Fine-Gray models (subdistribution HR, 1.31; 95% CI, 1.08-1.59). The matched Cox HR was 1.35 (95% CI, 1.09-1.66). Fully adjusted Cox HRs were 1.64 (95% CI, 1.15-2.35) for vascular dementia and 1.34 (95% CI, 0.92-1.93) for Alzheimer's disease. No interactions with cardiovascular condition status were detected. CONCLUSIONS: Sarcopenia assessed at recruitment was associated with all-cause dementia after incident AF/flutter. Prospective studies should assess the clinical value of muscle measurements near AF/flutter diagnosis.

Authors

Institutions

Publication Details

Journal
The journal of nutrition health & aging
Published
2026-11-18
DOI
https://doi.org/10.1016/j.jnha.2026.101036
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Baseline sarcopenia and subsequent dementia after incident atrial fibrillation or flutter in the UK Biobank

Yangyang Bao, Tianyou Ling, 罗庆志, Changjian Lin et al.
1 links
The journal of nutrition health & aging
Atrial Fibrillation Management and Outcomes
article

Baseline sarcopenia and subsequent dementia after incident atrial fibrillation or flutter in the UK Biobank

Yangyang Bao, Tianyou Ling, 罗庆志, Changjian Lin, Xiang Li, Wu Liqun, Wenqi Pan, Ning Zhang, Jin Qi, Yu Yu, Yue Wei, Yun Xie
article en

Abstract

BACKGROUND: The association between sarcopenia and dementia after incident atrial fibrillation or flutter (AF/flutter) remains uncertain. METHODS: We studied 30,743 UK Biobank participants free of AF/flutter at recruitment who subsequently had a first recorded AF/flutter event. Sarcopenia was assessed at recruitment; dementia follow-up began at that event. Analyses used Cox and Fine-Gray models, propensity-score matching and restricted cubic splines. Exploratory analyses tested interactions with AF/flutter, heart failure and coronary artery disease status at entry. RESULTS: Sarcopenia was present in 2,279 participants (7.4%). Over a median 4.27 years after AF/flutter entry, 1,155 developed dementia. Recruitment preceded entry by a median 8.50 years. Fully adjusted analyses included 26,430 participants and 998 all-cause dementia events. Sarcopenia was associated with all-cause dementia in Cox (hazard ratio [HR], 1.41; 95% confidence interval [CI], 1.16-1.72) and Fine-Gray models (subdistribution HR, 1.31; 95% CI, 1.08-1.59). The matched Cox HR was 1.35 (95% CI, 1.09-1.66). Fully adjusted Cox HRs were 1.64 (95% CI, 1.15-2.35) for vascular dementia and 1.34 (95% CI, 0.92-1.93) for Alzheimer's disease. No interactions with cardiovascular condition status were detected. CONCLUSIONS: Sarcopenia assessed at recruitment was associated with all-cause dementia after incident AF/flutter. Prospective studies should assess the clinical value of muscle measurements near AF/flutter diagnosis.

The journal of nutrition health & agingVol. 31(2)
Shanghai Jiao Tong University (CN), Ruijin Hospital (CN)
Good health and well-being
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon